Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy

Name: Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy
Creator: U.S. Department of Health & Human Services
Published: 2025-12-20T10:43:07+08:00

data.gov2025-12-20 收录

结肠直肠癌

药物疗效评估

数据链接：

https://catalog.data.gov/dataset/raltitrexed-tomudex-administration-in-patients-with-relapsed-metastatic-colorectal-cancer-数据链接链接失效反馈

官方服务：

资源简介：

Purpose The present study aimed at evaluating the efficacy of Raltitrexed, a specific thymidilate synthase inhibitor, in patients with advanced colorectal cancer...

研究目的：本研究旨在评估雷替曲塞（Raltitrexed，一种特异性胸苷酸合酶抑制剂（thymidilate synthase inhibitor））在晚期结直肠癌患者中的疗效……

提供机构：

U.S. Department of Health & Human Services